摘要
目的探讨行为激活技术对抑郁症患者的临床疗效。方法单相抑郁症患者42例随机分为联合治疗组(行为激活技术结合药物治疗)和对照组(单纯药物治疗),疗程10周。分别于治疗前、治疗后以及1年随访结束时采用汉密尔顿抑郁量表(HAM D)和生活质量综合评定问卷(GQOL I-74)评定临床疗效和生活质量情况。结果两组的HAM D总分低于治疗前,GQOL I-74总分高于治疗前,差异有统计学意义(P<0.01),而联合治疗组的生活质量情况改善程度较对照组更为明显(P<0.05);1年随访结束时联合治疗组病情复发率明显低于对照组(χ2=4.81,P<0.05),显著进步人数高于对照组(χ2=3.89,P<0.05)。结论联合治疗组的疗效优于对照组,行为激活技术治疗有较好的远期疗效和预防复发的作用。
Objective To explore the clinical efficacy of Behavioral Activation to Depression.Methods A total of 42 patients with unipolar depression were divided into behavioral activation therapy plus drug therapy group（combined treatment group）and drug therapy group by random block design for 10 weeks.Hamiltion depression scale（HAMD） was used to evaluate the clinical efficacy,and general quality of life inventory-74（GQOLI-74） was used to evaluate the patients′quality of life in the course of treatment and follow-up period.Results The total scores of HAMD reduced and the scores of GQOIL-74 increased significantly after 10 weeks for each group（P0.01）,Patients in combined treatment group had much better quality of life than patients in drug therapy group（P0.05）.After 1 year follow-up,The rate of the recurrence was lower significantly and improving was higher in combined treatment group than the drug therapy group.Conclusions Compared the drug therapy group,the combined treatment group has much better clinical efficacy,the behavioral activation technology＇s long-term result is good and can prevent recurrence.
出处
《中国健康心理学杂志》
2011年第10期1164-1165,共2页
China Journal of Health Psychology
基金
河北省2009年医学科学研究重点课题计划(20090061)
"青少年焦虑抑郁情绪的心理机制及干预策略"
